Chemotherapy - Bleomycin

Brand Name: Blenoxane

Bleomycin is a chemotherapy drug that is administered for the treatment of several types of cancer, including squamous cell carcinomas, testicular cancer, head and neck cancers, and lymphomas. It works as an antineoplastic drug, meaning that it is a tumor antibiotic and is toxic to fast growing cells.

This drug is usually used in the treatment of Hodgkin’s Disease, though it is also used in Non-Hodgkin’s Lymphomas. It is commonly used in conjunction with other chemotherapy drugs in the following regimens:

Drug Administration

There are many different methods for administering bleomycin. The drug may be given through an IV drip, through injection into the muscle, or through a chest tube into the pleural cavity – the cavity that holds the lungs. The type of administration depends on the type of cancer, the location of tumors, and the symptoms that a patient experiences prior to treatment.

Side Effects

Common side effects include fever and chills, alopecia (hair loss), skin reactions (stretch marks, skin peeling, redness), and thickening of the nails.

Less common side effects include nausea, mouth sores, and weight loss due to low appetite.

The most serious side effect of bleomycin is lung damage, though this effect is rare. Doctors should test and monitor patient lung health during and after treatment. Other rare conditions include the development of Raynaud’s phenomenon (discoloration of the fingers and toes) or allergic reaction.

Talk to your doctor if you experience these or any other symptoms while undergoing chemotherapy.

Dive Deeper

Resources

Related Articles

More Articles

More Articles

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...

Diffuse large B cell lymphoma prognosis is contingent upon several factors, and can be determined by using a well-...

The term 'metastatic lymphoma' does not refer to a diagnosis. Unlike many of the subtypes of lymphoma we have...

Diagnosing lymphoma is one of the more difficult diagnoses to make in cancer medicine, and contrary to perception, diagnosing lymphoma is not made...

Burkitt's lymphoma is an aggressive B-cell lymphoma that is common in children...

Treatment for Non-Hodgkin’s Lymphomas (NHL) differs from patient to patient. The regimen used depends on the type of...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Follicular lymphoma is classified as a Non-Hodgkin's Lymphoma. It is an indolent (slow-growing) cancer that affects...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

Lymphoma is not difficult to diagnose once a patient and doctor begin to look for signs of cancer. However, Lymphoma–especially...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

The lymphatic system, or lymph system, defends the body from foreign invasion by disease causing agents such as viruses, bacteria, or fungi. The...

Lymphoma is a cancer of the lymphatic system, causing B-cell or...